Shared mechanisms of musculoskeletal dysfunction in type 2 diabetes mellitus: Insights into future therapeutic directions (Review)
International Journal of Molecular Medicine · 2026
DOI: 10.3892/ijmm.2026.5955 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Medicine, 2026. Verfasst von Zhenhong He und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Musculoskeletal Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 2 diabetes mellitus (T2DM) profoundly affects the musculoskeletal system through multifactorial mechanisms. The present review systematically summarizes the impact of T2DM on skeletal muscle, tendon, tendon‑bone interface (TBI), and bone, highlighting their shared and tissue‑specific pathophysiological pathways. In skeletal muscle, impaired insulin signaling and mitochondrial dysfunction lead to reduced protein synthesis, enhanced proteolysis, and muscle atrophy. In tendons, advanced glycation end products accumulation and microangiopathy disrupt collagen metabolism and biomechanics. At the TBI, persistent hyperglycemia induces fibrocartilage fibrosis, impaired angiogenesis and disorganized stress transmission, ultimately weakening load‑bearing capacity. In bone, the imbalance between osteoblast and osteoclast activity, coupled with microvascular dysfunction and metabolic acidosis, results in reduced bone formation and increased fragility. Although the manifestations of T2DM differ among skeletal muscle, tendon, TBI and bone, these tissues share common pathological drivers, including metabolic dysregulation, chronic inflammation, oxidative stress, extracellular matrix remodeling, and impaired regenerative capacity. A deeper understanding of these shared mechanisms may facilitate the identification of novel therapeutic targets. Emerging technologies, including single‑cell RNA sequencing, regenerative medicine, and precision medicine, further provide new opportunities for early diagnosis and personalized management of diabetes‑related musculoskeletal disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China.
- College of Integrated Traditional Chinese and Western Medicine, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China.
Zitieren
APA
He, Z., Li, H., Luo, Y., Yu, Y., Li, S., Zhang, T., & Bao, D. (2026). Shared mechanisms of musculoskeletal dysfunction in type 2 diabetes mellitus: Insights into future therapeutic directions (Review). International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2026.5955
Vancouver
He Z, Li H, Luo Y, Yu Y, Li S, Zhang T, et al. Shared mechanisms of musculoskeletal dysfunction in type 2 diabetes mellitus: Insights into future therapeutic directions (Review). International Journal of Molecular Medicine. 2026. doi:10.3892/ijmm.2026.5955
BibTeX
@article{He2026,
author = {He, Zhenhong and Li, Hanyu and Luo, Yuhan and Yu, Yingying and Li, Siyu and Zhang, Tao and Bao, Dingsu},
title = {Shared mechanisms of musculoskeletal dysfunction in type 2 diabetes mellitus: Insights into future therapeutic directions (Review)},
journal = {International Journal of Molecular Medicine},
year = {2026},
doi = {10.3892/ijmm.2026.5955}
}
EUVIMED